“Optimized Non-Tumorigenic Hepatic Stellate Cell Line for Intranasal Delivery of Therapeutic Cargo to Central Nervous System”

https://pubmed.ncbi.nlm.nih.gov/38115217

A non-tumorigenic hepatic stellate cell line, LX-2, has been optimized for safe and effective intranasal delivery of therapeutic cargo to the central nervous system.